Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GYRE THERAPEUTICS, INC. has filed 1,598 SEC EDGAR filings since 16 Dec 2002

SEC filing history

Showing 926-950 of 1,000 matching filings.

Per page
25
Current page
38
3/A

3/A filing

Filing date
18 Dec 2014
Reporting date
11 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 - HODGES

Filing date
16 Dec 2014
Reporting date
11 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
16 Dec 2014
Reporting date
11 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - RICHARD

Filing date
12 Dec 2014
Reporting date
11 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - BLIXT

Filing date
12 Dec 2014
Reporting date
11 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - BROWN

Filing date
12 Dec 2014
Reporting date
11 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - SOUZA

Filing date
12 Dec 2014
Reporting date
11 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - DUNTON

Filing date
12 Dec 2014
Reporting date
11 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
14 Nov 2014
Reporting date
10 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
05 Nov 2014
Reporting date
05 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-51173

CT ORDER filing

Filing date
04 Nov 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Oct 2014
Reporting date
17 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Oct 2014
Reporting date
17 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Oct 2014
Reporting date
17 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Oct 2014
Reporting date
17 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
09 Oct 2014
Reporting date
08 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-82442

SCHEDULE 13D

Filing date
05 Sep 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
04 Sep 2014
Reporting date
02 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
06 Aug 2014
Reporting date
06 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
28 Jul 2014
Reporting date
28 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
14 Jul 2014
Reporting date
14 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82442

SC 13G/A filing

Filing date
10 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82442

SC 13G/A filing

Filing date
10 Jul 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .